SCHEMBL2928407

SCHEMBL2928407

CN(C)Cc1ccc2cc(C(=O)Nc3ccc(-c4ccc(Cl)cc4)cc3)ccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.54
PLAU P00749 9/20 0.54
LSS P48449 1/20 0.51
PLG P00747 4/20 0.49
PLAT P00750 4/20 0.49
KLKB1 P03952 3/20 0.49
PRSS1 P07477 3/20 0.49
F2 P00734 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
SLC2A1 P11166 1/20 0.48
F10 P00742 1/20 0.48
PTPN1 P18031 1/20 0.48
NR1H4 Q96RI1 1/20 0.48
ROCK2 O75116 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2929377 0.93 MCHR1 (0.60) MCHR1LSSKLKB1MEN1KMT2A
SCHEMBL2924753 0.84 PLAU (0.52) PLAUPLGPLATKLKB1PRSS1
SCHEMBL6308562 0.83 MCHR1 (0.58) MCHR1KLKB1MEN1KMT2ANPC1
SCHEMBL6305345 0.82 MCHR1 (0.52) MCHR1LSSKLKB1MEN1KMT2A
SCHEMBL2928350 0.81 MEN1 (0.55) MCHR1MEN1KMT2ANPC1RAB9A
SCHEMBL2925645 0.80 MCHR1 (0.55) MCHR1KLKB1NPC1RAB9AF10
SCHEMBL5645754 0.80 MCHR1 (0.68) MCHR1KLKB1MEN1KMT2ANPC1
SCHEMBL13177428 0.78 NPC1 (0.52) MCHR1MEN1KMT2ANPC1RAB9A
SCHEMBL13885524 0.77 KDM4E (0.67) MEN1KMT2ANPC1RAB9AROCK2
SCHEMBL2925533 0.75 MCHR1 (0.56) MCHR1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1285651-B1 MELANIN CONCENTRATING HORMONE ANTAGONISTS TAKEDA PHARMACEUTICAL (JP) 2010-09-01 EP disclosed
US-6930185-B2 Melanin-concentrating hormone antagonist TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-16 US disclosed
US-20040077628-A1 Melanin-concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-22 US disclosed
EP-1285651-A1 MELANIN CONCENTRATING HORMONE ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2003-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077628-A1 Melanin-concentrating hormone antagonist MCHR1, MC1R, MCHR2 MCHR1 1/4885PLAU 3555/4885LSS 3656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.